8,481 results
Search Results
2. Invited Papers 2
3. Invited Papers 1
4. Cervical screening: ESGO-EFC position paper of the European Society of Gynaecologic Oncology (ESGO) and the European Federation of Colposcopy (EFC).
5. Invited Papers (4-12).
6. Invited papers.
7. Review of survival analyses published in cancer journals.
8. The inhibition of formation of 3, 4-benzpyrene in cigarette smoke.
9. Immunotherapy in older patients with non-small cell lung cancer: Young International Society of Geriatric Oncology position paper.
10. Invited Papers 2.
11. 3,4-Benzpyrene in the Smoke of Cigarette Paper, Tobacco, and Cigarettes*.
12. Polycyclic hydrocarbons in cigarette smoke: the contribution made by the paper.
13. How do the media report cancer research? A study of the UK's BBC website.
14. Invited Papers (1-3).
15. Position paper by the UKCCCR Elderly Cancer Patients in Clinical Trials Working Group.
16. The impact of cancer research: how publications influence UK cancer clinical guidelines.
17. Separation of 3,4-Benzpyrene Metabolites by Paper Partition Chromatography.
18. Transforming post pandemic cancer services.
19. Invited papers.
20. Invited papers - Clinical Trial Updates Session.
21. The process of peer-review.
22. Invited Papers.
23. Invited Papers 1.
24. Invited Papers.
25. Invited Papers.
26. British Association for Cancer Research/Association of Cancer Physicians/British Oncological Association/Joint Symposium on 'Radiotherapy - 100 Years On' (incorporating the 1995 Gordon Hamilton-Fairley Memorial Lecture), 'The Tumour and its Environment' and 'Whither High Dose Chemotherapy?' and BACR Members' Proffered Papers
27. British Association for Cancer Research/Association of Cancer Physicians/Society for Drug Research Joint Symposium on `Membrane Transport - Biology and Therapeutics' and BACR Members' Proffered Papers.
28. Twenty-fifth annual general meeting of the British Association for Cancer Research*. Abstracts of invited and profferred papers.
29. Transition from laboratory to clinic in cancer treatment. Abstracts of symposium papers.
30. B.A.C.R. Abstracts of member proffered papers.
31. Imperial Cancer Research Fund British Association for Cancer Research. Joint symposium held at the Royal College of Surgeons, Lincolns Inn Fields, London 30 November-1 December 1978. Abstracts of papers.
32. The British Association for Cancer Research and The Section of Oncology, Royal Society of Medicine. Joint Joint Autumn Meeting at the Royal Society of Medicine, 1 Wimpole Street, London 4-5 October, 1977. Abstracts of Members' Proffered Papers.
33. Part I: Abstracts of Members' Proffered Papers.
34. Designing phase II trials in cancer: a systematic review and guidance.
35. 3, 4-Benzpyrene in the smoke of cigarette paper, tobacco, and cigarettes.
36. Routine psychosocial distress screening in radiotherapy: implementation and evaluation of a computerised procedure.
37. Body composition and cancer survival: a narrative review.
38. Steering decision making by terminology: oligometastatic versus argometastatic.
39. Writing Scientific Papers in English.
40. Occupational cancer burden in Great Britain.
41. From receipt to publication.
42. Support to early clinical decisions in drug development and personalised medicine with checkpoint inhibitors using dynamic biomarker-overall survival models.
43. The effect of time before diagnosis and treatment on colorectal cancer outcomes: systematic review and dose–response meta-analysis.
44. INVITED PAPERS.
45. Systematic review of cancer treatment programmes in remote and rural areas.
46. Inhibition of angiogenesis and murine tumour growth by laminarin sulphate.
47. Quantifying the effects of risk-stratified breast cancer screening when delivered in real time as routine practice versus usual screening: the BC-Predict non-randomised controlled study (NCT04359420).
48. Human papillomavirus vaccination in low-resource countries: lack of evidence to support vaccinating sexually active women.
49. Clinical reports of pulmonary metastasectomy for colorectal cancer: a citation network analysis.
50. The impact of FDA and EMEA guidelines on drug development in relation to Phase 0 trials.
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.